MedPath

A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens

Not Applicable
Conditions
Breast Cancer
Interventions
Device: MRI (magnetic resonance imaging)
Device: radiography
Registration Number
NCT01869335
Lead Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Brief Summary

Radiography of breast specimens is currently the only radiological procedure used to verify removal of microcalcifications and presence of tumor-free margins after breast surgical resection. Ex vivo MRI will be tested for its ability to detect residual tumor tissue not detected by radiography in resected breast tumor specimens and/or its ability to verify tumor-free margins in breast cancer detected by MRI only.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
260
Inclusion Criteria
  • Women with malignant breast disease identified by microcalcifications without clinically evident disease
  • Women candidate to breast preserving surgery
Exclusion Criteria
  • Cardiac pacemaker, defibrillators, cardiac monitors
  • Brain stimulators, implantable spinal stimulators
  • Vascular and aneurismal clips
  • Hemostatic clips
  • Infusion pumps
  • Glaucoma drainage implants
  • Metallic foreign body positioned in vital organ of the patients
  • Some heart valves
  • Some vascular access ports, infusion pumps and catheters
  • Permanent contraceptive tubal device
  • Kidney disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
MRI (magnetic resonance imaging)MRI (magnetic resonance imaging)Arm2: patients undergo MRI localization and ex vivo MRI after surgical resection.
radiographyradiographyArm1: patients undergo mammographic localizations and radiography of the specimen after surgical resection.
Primary Outcome Measures
NameTimeMethod
Diagnostic efficacy of Magnetic Resonance Imaging (MRI) versus radiography in evaluating tumor-free margins in breast cancer specimens2 years

Diagnostic efficacy will be evaluated by statistical analysis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondazione IRCCS Istituto Nazionale dei Tumori

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath